Search

Search Constraints

You searched for: Author/Creator Januzzi, J

Search Results

2. Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure. (14th October 2021)

3. Chronic obstructive pulmonary disease in heart failure: influence on circulating biomarkers and outcome. (25th November 2020)

4. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022)